Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.
| Revenue (Most Recent Fiscal Year) | $17.44M |
| Net Income (Most Recent Fiscal Year) | $-21.17M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.75 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -121.71% |
| Net Margin (Trailing 12 Months) | -121.37% |
| Return on Equity (Trailing 12 Months) | -849.22% |
| Return on Assets (Trailing 12 Months) | -96.11% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.24 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.24 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 3.31 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $-0.16 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.58 |
| Earnings per Share (Most Recent Fiscal Year) | $-2.07 |
| Diluted Earnings per Share (Trailing 12 Months) | $-2.07 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 13.49M |
| Free Float | 13.20M |
| Market Capitalization | $13.14M |
| Average Volume (Last 20 Days) | 0.35M |
| Beta (Past 60 Months) | 6.93 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.10% |
| Percentage Held By Institutions (Latest 13F Reports) | 26.35% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |